A new report from the Commonwealth Fund looking at healthcare coverage said the uninsured rate is basically unchanged from before President Trump took office, but that more people, primarily those who have coverage through work, are underinsured. By late fall of 2018, 12.4% of adults were uninsured, down from a high of 20% before the Affordable Care Act became law.
A new report from the Commonwealth Fund looking at healthcare coverage said the uninsured rate is basically unchanged from before President Trump took office, but that more people, primarily those who have coverage through work, are underinsured. By late fall of 2018, 12.4% of adults were uninsured, down from a high of 20% before the Affordable Care Act (ACA) became law.
Their latest Biennial Health Insurance Survey looks at the extent and quality of coverage for working-age adults by examining whether they have insurance, whether they had a coverage gap in the prior year, and whether high out-of-pocket (OOP) costs and deductibles are causing them to be underinsured, despite having continuous coverage throughout the year.
According to the report, people who are underinsured have high health plan deductibles and OOP medical expenses relative to their income. They are more likely to struggle paying medical bills or incur debt (47%) or go without care (41%). However, even among those with better insurance coverage, 23% had issues getting care and 25% had trouble paying medical bills or incurred debt.
Among those with insurance for a full year, 29% were underinsured in 2018, up from 23% in 2014.
More than half of Americans under age 65—about 158 million people—get their health insurance through an employer. About 25% of those either have a plan purchased through the individual insurance markets created by the ACA or are enrolled in Medicaid. The ACA mostly left the employer market alone.
Of those with health insurance through work, 28% were underinsured in 2018, up from 20% in 2014. People who bought plans through the individual market or the Marketplaces were the most likely to be underinsured (42%).
Having continuous coverage made a difference in whether people had access to preventive care and cancer screenings, even for those who were underinsured, the report said. The ACA includes a requirement that that insurers and employers cover these services without cost sharing. The majority of those surveyed had a source to regular care. Of women aged 40 to 64, 71% who had continuous coverage received mammograms.
Most health policy experts have expected healthcare coverage provided under the ACA to become more limited after the Trump administration took a variety of measures to curb it after an ACA repeal vote failed to pass Congress in 2017. In October of that year, Trump stopped paying the cost-sharing reduction subsidies that helped insurers keep premiums down for lower-income Americans. In December 2017, Congress passed a repeal of the individual mandate tax penalty.
Last year, rules were changed to expand the use of short-term, limited-duration health plans and association health plans, which may offer more limited coverage than plans sold on the exchanges. The administration has also started approving state waivers to condition certain Medicaid benefits to work requirements.
In its report, the Commonwealth Fund made 3 proposals to expand coverage and improve affordability, although most of them are at odds with the administration and Republicans in Congress.
They include things like expanding Medicaid in all states without restrictions, placing limits on plans that do not comply with the ACA, establishing state or federal reinsurance programs to lower ACA premiums (although CMS is allowing some states to create such programs), offering cost-sharing reduction subsidies to more people who earn too much to qualify for them, excluding more health services from plan deductibles in all health plans, and increasing the required minimum value of employer plans.
It also suggested restoring funding for the ACA outreach and navigator program for the 2020 open enrollment period. The budget for that program has shrunk from $63 million at its peak to just $10 million, as the Trump administration said the program was not cost-effective.
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More